Posted on

Isodiol International Inc. Provides Investor Update

October 18, 2017 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global Bioactive Phytoceutical innovator specializing in the development of pharmaceutical and nutraceutical products, reports the Canadian Securities Exchange (CSE) will continue to welcome companies with links to the US cannabis market, a contrast to the statement […]

Posted on

Isodiol International Inc to Implement Blockchain Technology for Payment Processing

October 17, 2017 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global Bioactive Phytoceutical innovator specializing in the development of pharmaceutical and nutraceutical products, announced today that it is in the final stages of advanced due diligence for implementing Blockchain technology for payment processing.  The company […]

Posted on

Isodiol International Provides Corporate Update

October 13, 2017 – Vancouver, BC –Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”) a global Bioactive Phytoceutical innovator specializing in the development of pharmaceutical and nutraceutical products, announces fiscal 2018 Q2 revenues of it’s wholly owned subsidiary ISO International LLC of, $4.07 million USD ($5.1 million CDN) compared to fiscal 2018 […]

Posted on

Isodiol International to Present at New West Summit Cannabis Conference in Oakland

October 10, 2017 – Vancouver, BC –Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”) a global Bioactive Phytoceutical innovator specializing in the development of pharmaceutical and nutraceutical products, announced today Marvin Washington, former NFL athlete and brand ambassador for Isodiol, will be speaking at the New West Summit Cannabis Conference being held at […]

Posted on

Isodiol International Inc. Commences Approval Process to Bring Isodiol to Chilean Market

October 4, 2017 – Vancouver, BC –Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”) a global Bioactive Phytoceutical innovator specializing in the development of pharmaceutical and nutraceutical products, is pleased to announce that the Company has officially initiated the approval process to begin exporting its flagship product, Isoderm to Chile. Marcos Agramont, […]

Posted on

Isodiol International Inc. Announces Formation of IsoLabs, Plans to Expand With THC Product Offerings

September 28, 2017 – Vancouver, BC –Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”) a global cannabis innovator specializing in the development of pharmaceutical and consumer products is pleased to announce the formation of IsoLabs International, a new division that will focus in the licensed medical marijuana markets in both North America […]

Posted on

Isodiol International Inc. Announces North 6th Agency as PR and Social Media Agency of Record

September 27, 2017 – Vancouver, BC –Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”) a global cannabis innovator specializing in the development of pharmaceutical and consumer products announces that it is proud to name North 6th Agency (N6A), an award-winning brand communications agency based in New York and Toronto, the Company’s PR […]

Posted on

Isodiol International Inc. Commences Process to List on the Australian Stock Exchange

September 12, 2017 – Vancouver, BC –Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”) a global cannabis innovator specializing in the development of pharmaceutical and consumer products announces that it has initiated the process of obtaining a secondary listing on the Australian Stock Exchange (ASX) and expects this process to be […]

Posted on

Isodiol International Inc. Announces Launching Phytoceutical Division

September 5, 2017 – Vancouver, BC –Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”) a global cannabis innovator specializing in the development of pharmaceutical and consumer products announces that it is proud to be launching a new Phytoceutical Division that will focus on cannabinoids and terpenes derived from non-cannabis sources. Proprietary […]

Posted on

Isodiol International Inc Announces Distribution Agreement for South America

August 30th, 2017 – Vancouver, BC –Isodiol International Inc. (CSE: ISOL) (OTC: LAGBF) (FSE: LB6A.F) (the “Company” or “Isodiol”) a global cannabinoid innovator specializing in the development of pharmaceutical and consumer products announces it has signed a distribution partnership with FarmaUSA™, a leading global wholesale distributor of imported pharmaceutical products in South America. This is the latest […]